Therini Bio, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.therinibio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Assess THN391 in Subjects With Alzheimer's Disease
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Therini Bio Inc.
- Target Recruit Count
- 12
- Registration Number
- 2024-519899-72-00
- Locations
- π³π±
Amsterdam UMC, Amsterdam, New Hampshire, Netherlands
π³π±CTC-Netherlands, Groningen, Netherlands
π¬π§Scottish Brain Sciences, Edinburgh, United Kingdom
News
No news found